Mutation Profile of Resected EGFR‐Mutated Lung Adenocarcinoma by Next‐Generation Sequencing

BACKGROUND. The efficacy of adjuvant targeted therapy for operable lung cancer is still under debate. Comprehensive genetic profiling is needed for detecting co‐mutations in resected epidermal growth factor receptor (EGFR)‐mutated lung adenocarcinoma (ADC), which may interfere the efficacy of adjuva...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncologist
Autores principales: Zhao, Ze‐Rui, Lin, Yao‐Bin, Ng, Calvin S.H., Zhang, Rong, Wu, Xue, Ou, Qiuxiang, Chen, Wendan, Zhou, Wen‐Jie, Lin, Yong‐Bin, Su, Xiao‐Dong, Shao, Yang W., Long, Hao
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Lung Cancer
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6795151/
https://ncbi.nlm.nih.gov/pubmed/30872465
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0567
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares